CN Patent

CN110709398A — 氘代丁苯那嗪的类似物、其制备方法及用途

Assigned to Ospex Pharmaceuticals · Expires 2020-01-17 · 6y expired

What this patent protects

本公开内容针对氘代丁苯那嗪(deutetrabenazine)类似物、包含氘代丁苯那嗪(deutetrabenazine)类似物的组合物及检测包含氘代丁苯那嗪的组合物中的氘代丁苯那嗪类似物的方法。

USPTO Abstract

本公开内容针对氘代丁苯那嗪(deutetrabenazine)类似物、包含氘代丁苯那嗪(deutetrabenazine)类似物的组合物及检测包含氘代丁苯那嗪的组合物中的氘代丁苯那嗪类似物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN110709398A
Jurisdiction
CN
Classification
—
Expires
2020-01-17
Drug substance claim
No
Drug product claim
No
Assignee
Ospex Pharmaceuticals
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.